Browse Experiments | ReplicateScience

source-backed-method-package95/100

High-mobility Group Protein 1/ Receptor for Advanced Glycation End Products/ Nuclear Factor-κB Signalling Pathway Contributes to the Pathogenic Process of Striatal Neuron Impairment in the Rat Model of Parkinson's Disease methods

yaofeng zhu

High-mobility Group Protein 1/ Receptor for Advanced Glycation End Products/ Nuclear Factor-κB Signalling Pathway Contributes to the Pathogenic Process of Striatal Neuron Impairment in the Rat Model of Parkinson's Disease

ratMethods-Backed

20260 equipment4 steps4 quotes

Browse reproducible experimental methods.

Opioid Receptor Antagonism Attenuates Antidepressant Effects of Ketamine methods

Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model methods

Antipurinergic therapy corrects the autism-like features in the Fragile X ( Fmr1 knockout) mouse model methods

Hyponatremia-Induced Osteoporosis methods

Propranolol Administration During Morphine Addiction Attenuates Reinstatement of Drug-Aversive Memories Caused by Exposure to Stressful Stimuli methods

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life methods

An injectable hydrogel enhances tissue repair after spinal cord injury by promoting extracellular matrix remodeling methods

Perineuronal nets stabilize the grid cell network methods

High-mobility Group Protein 1/ Receptor for Advanced Glycation End Products/ Nuclear Factor-κB Signalling Pathway Contributes to the Pathogenic Process of Striatal Neuron Impairment in the Rat Model of Parkinson's Disease methods

Chronic Organic Magnesium Supplementation Enhances Tissue-Specific Bioavailability and Functional Capacity in Rats: A Focus on Brain, Muscle, and Vascular Health methods

Low-Cost Avoidance Behaviors are Resistant to Fear Extinction in Humans methods

Circadian control of brain glymphatic and lymphatic fluid flow methods